The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

May. 22, 2015
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Weiguo Liu, Princeton Junction, NJ (US);

Scott D. Edmondson, Clark, NJ (US);

Zhuyan Guo, Scotch Plains, NJ (US);

Eric Mertz, Fair Lawn, NJ (US);

Anthony K. Ogawa, New Providence, NJ (US);

Sung-Sau So, Verona, NJ (US);

Wanying Sun, Edison, NJ (US);

Linda L. Brockunier, Orange, NJ (US);

Amjad Ali, Freehold, NJ (US);

Rongze Kuang, Green Brook, NJ (US);

Heping Wu, Edison, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/10 (2006.01); C07D 401/10 (2006.01); C07D 213/89 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 413/10 (2006.01);
U.S. Cl.
CPC ...
C07D 417/10 (2013.01); C07D 213/89 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 413/10 (2013.01);
Abstract

The present invention provides a compound of Formula I (The chemical formula should be inserted here.) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.


Find Patent Forward Citations

Loading…